top of page
Co-Founder and Co-Managing Partner, P. Raviprasad named as a Litigation Star: Commercial and Transactions by the Benchmark Litigation Asia-Pacific 2025
We are delighted to announce that our Co-Founder and Co-Managing Partner, Mr. P. Raviprasad was recognized as a “Litigation Star” for...
May 27, 2025


Pravesha Industries sells majority stake to PAG for $200 Mn in pharma packaging dea Tempus law facilitates
Tempus Law Associates advised Pravesha Industries Private Limited in the $200 million majority stake sale to PAG, a private equity investment rm. Pravesha, established in 1999 leading Indian pharma packaging company, whose products predominantly serve develo markets such as the U.S. and Euro Tempus Law Associates represented Pravesha Industries Private Limited, a pharma-focused packaging company, and its existing promoters in the $200 million sale of a majority stake to PAG,
Apr 20, 2025


Tempus Law, AZB act on PAG’s USD200m packaging acquisition
Tempus Law Associates and AZB & Partners have assisted parties involved in private equity firm PAG acquiring a majority stake in pharmaceuticals packaging company Pravesha Industries for USD200 million. Co-founder and co-managing partner Sundari R Pisupati led the Tempus transaction team, representing Pravesha Industries and its promoters. Associate partner Raghav Agarwal, senior associates Sindhu Akella and Bhaskar Rekapalli, associate Nisha Agarwal and company secretary Ras
Feb 17, 2025


Tempus Law acts on Pennar - Zetwerk JV
Tempus Law and Vertices Partners advised Pennar Industries and Zetwerk Manufacturing Businesses on their joint venture agreement for the manufacturing of solar modules. Tempus Law represented Pennar Industries, who is holding a 45% stake in this JV. The transaction team consisted of Co-Founder and Co-Managing Partner, Ms. Sundari R. Pisupati, Associate Partner, Raghav Agarwal and Senior Associate, Shreshtha Sarkar. The companies signed an agreement on December 31, 2024, to fo
Feb 3, 2025


Tempus Law Associates and CAM advises in Aryastha Life Sciences Series A funding from Vessella Group
Aryastha Life Sciences, a leading Contract Research and Development Organization in healthcare, has achieved a major milestone by successfully concluding its Series A funding with significant backing from Vessella Group, a prominent investor in India. Tempus Law Associates and Cyril Amarchand Mangaldas structured the business legally. While specific Series A terms remain undisclosed, Aryastha's partnership with Vessella promises innovation and quality healthcare services worl
Aug 31, 2023
bottom of page